301263 泰恩康
已收盘 07-13 15:00:00
资讯
新帖
简况
泰恩康(301263)披露控股股东部分股份解除质押公告,7月6日股价下跌1.59%
证券之星 · 07-06
泰恩康(301263)披露控股股东部分股份解除质押公告,7月6日股价下跌1.59%
7月1日泰恩康涨5.32%,大成积极成长混合A基金重仓该股
证券之星 · 07-01
7月1日泰恩康涨5.32%,大成积极成长混合A基金重仓该股
泰恩康(301263)披露控股股东部分股份质押公告,6月30日股价下跌3.94%
证券之星 · 06-30
泰恩康(301263)披露控股股东部分股份质押公告,6月30日股价下跌3.94%
泰恩康(301263)股东郑汉杰质押1150万股,占总股本2.25%
证券之星 · 06-30
泰恩康(301263)股东郑汉杰质押1150万股,占总股本2.25%
股市必读:6月29日泰恩康现1笔折价32.3%的大宗交易 合计成交2779.7万元
证券之星 · 06-30
股市必读:6月29日泰恩康现1笔折价32.3%的大宗交易 合计成交2779.7万元
6月29日泰恩康涨18.17%,大成积极成长混合A基金重仓该股
证券之星 · 06-29
6月29日泰恩康涨18.17%,大成积极成长混合A基金重仓该股
泰恩康(301263.SZ)子公司收到复方硫酸钠片药品注册证书
智通财经 · 06-25
泰恩康(301263.SZ)子公司收到复方硫酸钠片药品注册证书
股市必读:6月18日泰恩康现1笔折价23.48%的大宗交易 合计成交2093.85万元
证券之星 · 06-22
股市必读:6月18日泰恩康现1笔折价23.48%的大宗交易 合计成交2093.85万元
每周股票复盘:泰恩康(301263)拟回购1亿至2亿元股份
证券之星 · 06-21
每周股票复盘:泰恩康(301263)拟回购1亿至2亿元股份
泰恩康(301263)披露回购公司股份方案公告,6月17日股价下跌1.72%
证券之星 · 06-17
泰恩康(301263)披露回购公司股份方案公告,6月17日股价下跌1.72%
泰恩康(301263.SZ)拟1亿元至2亿元回购公司股份
智通财经 · 06-16
泰恩康(301263.SZ)拟1亿元至2亿元回购公司股份
6月8日泰恩康跌5.71%,大成积极成长混合A基金重仓该股
证券之星 · 06-08
6月8日泰恩康跌5.71%,大成积极成长混合A基金重仓该股
泰恩康最新公告:控股股东提议1亿至2亿元回购公司股份
证券之星 · 06-04
泰恩康最新公告:控股股东提议1亿至2亿元回购公司股份
6月4日泰恩康跌5.05%,大成积极成长混合A基金重仓该股
证券之星 · 06-04
6月4日泰恩康跌5.05%,大成积极成长混合A基金重仓该股
泰恩康:玫瑰痤疮适应症目前已完成IIa期全部受试者入组并启动IIb期临床试验
证券之星 · 06-04
泰恩康:玫瑰痤疮适应症目前已完成IIa期全部受试者入组并启动IIb期临床试验
泰恩康:抗衰老及阿尔兹海默症的研发经费未被纳入公司可转债募集资金使用方案
证券之星 · 06-04
泰恩康:抗衰老及阿尔兹海默症的研发经费未被纳入公司可转债募集资金使用方案
泰恩康:CKBA乳膏联合NB-UVB方案300例样本评估疗效与安全性
证券之星 · 06-04
泰恩康:CKBA乳膏联合NB-UVB方案300例样本评估疗效与安全性
6月3日泰恩康创60日新低,大成积极成长混合A基金重仓该股
证券之星 · 06-03
6月3日泰恩康创60日新低,大成积极成长混合A基金重仓该股
泰恩康(301263)披露控股子公司CKBA乳膏玫瑰痤疮适应症IIa期临床试验完成全部受试者入组暨提前启动IIb期临床试验的公告,6月01日股价上涨0.28%
证券之星 · 06-01
泰恩康(301263)披露控股子公司CKBA乳膏玫瑰痤疮适应症IIa期临床试验完成全部受试者入组暨提前启动IIb期临床试验的公告,6月01日股价上涨0.28%
医保局发布医保目录调整方案;内蒙古检查售卖集采药违规药店
21世纪经济报道 · 06-01
医保局发布医保目录调整方案;内蒙古检查售卖集采药违规药店
加载更多
公司概况
公司名称:
广东泰恩康医药股份有限公司
所属行业:
批发业
上市日期:
2022-03-29
主营业务:
广东泰恩康医药股份有限公司的主营业务是代理运营及研发、生产、销售医药产品、医疗器械、卫生材料并提供医药技术服务与技术转让等。公司的主要产品是盐酸达泊西汀片、他达拉非片、枸橼酸西地那非口崩片、和胃整肠丸、沃丽汀、风油精、六味地黄丸、藿香正气丸、奥硝唑注射液。公司自主研发的“爱廷玖”盐酸达泊西汀片为首个国产PE用药,2020年8月正式投放市场,目前在达泊西汀院外渠道市场稳居头部地位,尤其在线下零售市场形成显著品牌优势。
发行价格:
19.93
{"stockData":{"symbol":"301263","market":"SZ","secType":"STK","nameCN":"泰恩康","latestPrice":19.94,"timestamp":1783926222000,"preClose":20.97,"halted":0,"volume":6263082,"delay":0,"changeRate":-0.0491,"floatShares":364000000,"shares":511000000,"eps":0.0503,"marketStatus":"已收盘","change":-1.03,"latestTime":"07-13 15:00:00","open":20.77,"high":21.29,"low":19.76,"amount":127000000,"amplitude":0.073,"askPrice":19.95,"askSize":130,"bidPrice":19.94,"bidSize":63,"shortable":0,"etf":0,"ttmEps":0.0503,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1783992600000},"marketStatusCode":5,"adr":0,"adjPreClose":20.97,"symbolType":"stock","openAndCloseTimeList":[[1783906200000,1783913400000],[1783918800000,1783926000000]],"highLimit":23.07,"lowLimit":18.87,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":510597000,"isCdr":false,"pbRate":6.31,"roa":"--","peRate":396.421471,"roe":"1.7%","epsLYR":0.07,"committee":0.277778,"marketValue":10181000000,"turnoverRate":0.0172,"status":1,"floatMarketCap":7264000000},"requestUrl":"/m/hq/s/301263","defaultTab":"news","newsList":[{"id":"2649277376","title":"泰恩康(301263)披露控股股东部分股份解除质押公告,7月6日股价下跌1.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2649277376","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649277376?lang=zh_cn&edition=full","pubTime":"2026-07-06 22:31","pubTimestamp":1783348277,"startTime":"0","endTime":"0","summary":"广东泰恩康医药股份有限公司于2026年7月6日发布公告,公司控股股东、实际控制人郑汉杰先生所持有的33,000,000股公司股份已于2026年7月3日办理了解除质押手续,占其所持股份比例的31.12%,占公司总股本的6.46%,质权人为北方国际信托股份有限公司。本次解除质押后,郑汉杰累计质押股份为21,620,000股,占其所持股份的20.39%。截至公告日,郑汉杰及其一致行动人孙伟文合计持有公司股份185,513,868股,累计质押股份50,294,000股,占合计持股的27.11%,占公司总股本的9.85%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070600037660.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301263"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648164825","title":"7月1日泰恩康涨5.32%,大成积极成长混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2648164825","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648164825?lang=zh_cn&edition=full","pubTime":"2026-07-01 16:55","pubTimestamp":1782896140,"startTime":"0","endTime":"0","summary":"证券之星消息,7月1日泰恩康涨5.32%,收盘报21.58元,换手率3.47%,成交量12.64万手,成交额2.66亿元。根据2026基金Q1季报公募基金重仓股数据,重仓该股的公募基金共4家,其中持有数量最多的公募基金为大成基金的大成积极成长混合A。大成积极成长混合A目前规模为9.3亿元,最新净值1.276,较上一交易日上涨2.16%,近一年上涨50.29%。大成积极成长混合A的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070100031776.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301263","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647554023","title":"泰恩康(301263)披露控股股东部分股份质押公告,6月30日股价下跌3.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2647554023","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647554023?lang=zh_cn&edition=full","pubTime":"2026-06-30 22:16","pubTimestamp":1782828975,"startTime":"0","endTime":"0","summary":"截至2026年6月30日收盘,泰恩康报收于20.49元,较前一交易日下跌3.94%,最新总市值为104.62亿元。该股当日开盘21.0元,最高21.28元,最低20.12元,成交额达3.06亿元,换手率为4.09%。广东泰恩康医药股份有限公司于2026年6月30日发布公告,公司控股股东、实际控制人郑汉杰先生将其持有的11,500,000股公司股份质押给中原信托有限公司,占其所持股份比例10.84%,占公司总股本比例2.25%。郑汉杰本次质押后累计质押股份54,620,000股,占其所持股份51.50%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026063000046920.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301263"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647537964","title":"泰恩康(301263)股东郑汉杰质押1150万股,占总股本2.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2647537964","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647537964?lang=zh_cn&edition=full","pubTime":"2026-06-30 18:33","pubTimestamp":1782815617,"startTime":"0","endTime":"0","summary":"证券之星消息,泰恩康6月30日公开信息显示,股东郑汉杰向中原信托有限公司合计质押1150.0万股,占总股本2.25%。质押详情见下表:截止本公告日,股东郑汉杰已累计质押股份5462.0万股,占其持股总数的51.5%,股东孙伟文已累计质押股份2867.4万股,占其持股总数的36.09%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026063000037434.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301263"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647755306","title":"股市必读:6月29日泰恩康现1笔折价32.3%的大宗交易 合计成交2779.7万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2647755306","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647755306?lang=zh_cn&edition=full","pubTime":"2026-06-30 01:37","pubTimestamp":1782754629,"startTime":"0","endTime":"0","summary":"截至2026年6月29日收盘,泰恩康报收于21.33元,上涨18.17%,换手率7.26%,成交量26.46万手,成交额5.32亿元。当日关注点交易信息汇总:6月29日泰恩康主力资金净流入859.94万元,游资资金净流出1402.59万元。大宗交易6月29日泰恩康发生1笔折价32.3%的大宗交易,合计成交2779.7万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026063000001022.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301263","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647732322","title":"6月29日泰恩康涨18.17%,大成积极成长混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2647732322","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647732322?lang=zh_cn&edition=full","pubTime":"2026-06-29 16:54","pubTimestamp":1782723284,"startTime":"0","endTime":"0","summary":"证券之星消息,6月29日泰恩康涨18.17%创60日新低,收盘报21.33元,换手率7.26%,成交量26.46万手,成交额5.32亿元。根据2026基金Q1季报公募基金重仓股数据,重仓该股的公募基金共4家,其中持有数量最多的公募基金为大成基金的大成积极成长混合A。大成积极成长混合A目前规模为9.3亿元,最新净值1.254,较上一交易日下跌3.02%,近一年上涨49.64%。大成积极成长混合A的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900024932.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301263"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646987566","title":"泰恩康(301263.SZ)子公司收到复方硫酸钠片药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2646987566","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646987566?lang=zh_cn&edition=full","pubTime":"2026-06-25 16:57","pubTimestamp":1782377870,"startTime":"0","endTime":"0","summary":"智通财经APP讯,泰恩康(301263.SZ)发布公告,公司全资子公司山东华铂凯盛生物科技有限公司于近日收到国家药品监督管理局签发的复方硫酸钠片《药品注册证书》。该药品是最早由美国FDA于2020年11月批准的一种新型口服固体片剂肠道清洁剂,作用机制是硫酸钠和硫酸镁的渗透作用产生导泻作用,用于成人结肠镜检查前的肠道准备工作。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1458681.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301263","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645016363","title":"股市必读:6月18日泰恩康现1笔折价23.48%的大宗交易 合计成交2093.85万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2645016363","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645016363?lang=zh_cn&edition=full","pubTime":"2026-06-22 04:09","pubTimestamp":1782072551,"startTime":"0","endTime":"0","summary":"截至2026年6月18日收盘,泰恩康报收于20.27元,上涨4.59%,换手率2.23%,成交量8.13万手,成交额1.64亿元。交易信息汇总资金流向6月18日主力资金净流入380.17万元,占总成交额0.0%;游资资金净流出557.22万元,占总成交额0.0%;散户资金净流入177.04万元,占总成交额0.0%。大宗交易6月18日泰恩康发生1笔大宗交易,折价23.48%,成交金额2093.85万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062200001433.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301263","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645096691","title":"每周股票复盘:泰恩康(301263)拟回购1亿至2亿元股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2645096691","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645096691?lang=zh_cn&edition=full","pubTime":"2026-06-21 02:59","pubTimestamp":1781981947,"startTime":"0","endTime":"0","summary":"截至2026年6月18日收盘,泰恩康报收于20.27元,较上周的18.85元上涨7.53%。本周,泰恩康6月18日盘中最高价报20.6元。泰恩康当前最新总市值103.5亿元,在化学制药板块市值排名46/150,在两市A股市值排名1909/5206。交易信息汇总6月18日泰恩康发生1笔大宗交易,折价23.48%,合计成交2093.85万元。公司公告汇总广东泰恩康医药股份有限公司于2026年6月16日召开第五届董事会第十九次会议,审议通过《关于回购公司股份方案的议案》。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062100000918.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301263"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644717868","title":"泰恩康(301263)披露回购公司股份方案公告,6月17日股价下跌1.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2644717868","media":"证券之星","labels":["buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644717868?lang=zh_cn&edition=full","pubTime":"2026-06-17 17:35","pubTimestamp":1781688951,"startTime":"0","endTime":"0","summary":"截至2026年6月17日收盘,泰恩康报收于19.38元,较前一交易日下跌1.72%,最新总市值为98.95亿元。本次回购股份旨在维护公司价值及股东权益,回购期限为董事会审议通过之日起不超过3个月。预计回购股份数量为286.53万股至573.07万股,占公司总股本的0.56%至1.12%。回购股份将在披露回购结果后十二个月后出售,并在三年内完成出售,未能出售的将依法注销。本次回购不会影响公司正常经营和持续上市地位。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061700030616.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301263"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643512753","title":"泰恩康(301263.SZ)拟1亿元至2亿元回购公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2643512753","media":"智通财经","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643512753?lang=zh_cn&edition=full","pubTime":"2026-06-16 17:51","pubTimestamp":1781603487,"startTime":"0","endTime":"0","summary":"智通财经APP讯,泰恩康(301263.SZ)发布公告,公司拟使用自有资金和自筹资金以集中竞价交易方式回购公司A股股份,用于维护公司价值及股东权益所必需,回购股份的资金总额不低于人民币1亿元且不超过人民币2亿元(均包含本数),回购股份的价不超过人民币34.90元/股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1455006.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0250","301263"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641100964","title":"6月8日泰恩康跌5.71%,大成积极成长混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2641100964","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641100964?lang=zh_cn&edition=full","pubTime":"2026-06-08 17:06","pubTimestamp":1780909604,"startTime":"0","endTime":"0","summary":"证券之星消息,6月8日泰恩康跌5.71%创60日新低,收盘报18.51元,换手率2.46%,成交量8.96万手,成交额1.68亿元。根据2026基金Q1季报公募基金重仓股数据,重仓该股的公募基金共4家,其中持有数量最多的公募基金为大成基金的大成积极成长混合A。大成积极成长混合A目前规模为9.3亿元,最新净值1.243,较上一交易日下跌2.97%,近一年上涨48.86%。大成积极成长混合A的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060800022859.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301263"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640152991","title":"泰恩康最新公告:控股股东提议1亿至2亿元回购公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2640152991","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640152991?lang=zh_cn&edition=full","pubTime":"2026-06-04 19:50","pubTimestamp":1780573811,"startTime":"0","endTime":"0","summary":"泰恩康(301263.SZ)公告称,公司收到控股股东、实际控制人、董事长郑汉杰提议,拟使用自有资金和自筹资金以集中竞价交易方式回购公司股份,回购资金总额不低于1亿元且不超过2亿元,回购价格上限不高于董事会审议通过前三十个交易日股票交易均价的150%,回购期限为董事会审议通过后三个月内。回购股份将用于维护公司价值及股东权益,并在披露结果后12个月后出售或三年内未使用部分予以注销。以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060400037356.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301263"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640153426","title":"6月4日泰恩康跌5.05%,大成积极成长混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2640153426","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640153426?lang=zh_cn&edition=full","pubTime":"2026-06-04 16:46","pubTimestamp":1780562808,"startTime":"0","endTime":"0","summary":"证券之星消息,6月4日泰恩康跌5.05%创60日新低,收盘报18.81元,换手率2.05%,成交量7.48万手,成交额1.43亿元。根据2026基金Q1季报公募基金重仓股数据,重仓该股的公募基金共4家,其中持有数量最多的公募基金为大成基金的大成积极成长混合A。大成积极成长混合A目前规模为9.3亿元,最新净值1.279,较上一交易日上涨0.24%,近一年上涨55.8%。大成积极成长混合A的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060400028762.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301263"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640133962","title":"泰恩康:玫瑰痤疮适应症目前已完成IIa期全部受试者入组并启动IIb期临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2640133962","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640133962?lang=zh_cn&edition=full","pubTime":"2026-06-04 09:12","pubTimestamp":1780535525,"startTime":"0","endTime":"0","summary":"证券之星消息,泰恩康(301263)06月03日在投资者关系平台上答复投资者关心的问题。投资者提问:请问下ckba治疗玫瑰痤疮2b期方案入组人数和时间和2a期一样还是有其他变化?顺利的话预计多久能读出数据并进入3期?泰恩康回复:您好,玫瑰痤疮适应症目前已完成IIa期全部受试者入组并启动IIb期临床试验,目标2027年上半年完成II期、下半年进入III期。感谢您对公司的关注。本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060400005478.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301263","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640133612","title":"泰恩康:抗衰老及阿尔兹海默症的研发经费未被纳入公司可转债募集资金使用方案","url":"https://stock-news.laohu8.com/highlight/detail?id=2640133612","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640133612?lang=zh_cn&edition=full","pubTime":"2026-06-04 09:09","pubTimestamp":1780535365,"startTime":"0","endTime":"0","summary":"根据公司2026年5月披露的可转债募集资金使用可行性分析报告中,创新药研发项目主要聚焦CKBA系列三个品种的临床研究,抗衰老及阿尔兹海默症的研发经费未被纳入公司可转债募集资金使用方案,若后续有调整,公司将及时履行信息披露义务,请您关注公司后续发布的可转债方案相关公告。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060400005288.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301263"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640413351","title":"泰恩康:CKBA乳膏联合NB-UVB方案300例样本评估疗效与安全性","url":"https://stock-news.laohu8.com/highlight/detail?id=2640413351","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640413351?lang=zh_cn&edition=full","pubTime":"2026-06-04 09:06","pubTimestamp":1780535190,"startTime":"0","endTime":"0","summary":"证券之星消息,泰恩康06月03日在投资者关系平台上答复投资者关心的问题。泰恩康回复:您好,公司于2026年5月29日完成CKBA乳膏儿童白癜风II期临床试验首例受试者入组,其他受试者招募和筛选工作正在加快推进。目前国内儿童白癜风治疗手段有限,公司采用CKBA 乳膏联合窄谱中波紫外线 方案,300例样本可充分评估联合疗法在儿童中的疗效持续性与安全性,为后续III期临床试验提供高质量数据支撑。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060400005204.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301263","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640797763","title":"6月3日泰恩康创60日新低,大成积极成长混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2640797763","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640797763?lang=zh_cn&edition=full","pubTime":"2026-06-03 16:42","pubTimestamp":1780476143,"startTime":"0","endTime":"0","summary":"证券之星消息,6月3日泰恩康创60日新低,收盘报19.81元,当日跌2.37%,换手率1.4%,成交量5.08万手,成交额1.02亿元。根据2026基金Q1季报公募基金重仓股数据,重仓该股的公募基金共4家,其中持有数量最多的公募基金为大成基金的大成积极成长混合A。大成积极成长混合A目前规模为9.3亿元,最新净值1.276,较上一交易日上涨3.32%,近一年上涨55.8%。大成积极成长混合A的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060300033671.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301263"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640057958","title":"泰恩康(301263)披露控股子公司CKBA乳膏玫瑰痤疮适应症IIa期临床试验完成全部受试者入组暨提前启动IIb期临床试验的公告,6月01日股价上涨0.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640057958","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640057958?lang=zh_cn&edition=full","pubTime":"2026-06-01 18:18","pubTimestamp":1780309118,"startTime":"0","endTime":"0","summary":"截至2026年6月1日收盘,泰恩康报收于21.11元,较前一交易日上涨0.28%,最新总市值为107.79亿元。公告显示,公司控股子公司江苏博创园生物医药科技有限公司自主研发的1类创新药CKBA乳膏玫瑰痤疮适应症IIa期临床试验完成全部受试者入组,获得初步积极有效的试验数据。IIa期临床试验为单中心、开放性、单臂设计,计划入组15例,已全部完成。目前IIb期临床试验方案已制定,研究机构初步筛选完成。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060100029802.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301263","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640981365","title":"医保局发布医保目录调整方案;内蒙古检查售卖集采药违规药店","url":"https://stock-news.laohu8.com/highlight/detail?id=2640981365","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640981365?lang=zh_cn&edition=full","pubTime":"2026-06-01 08:01","pubTimestamp":1780272073,"startTime":"0","endTime":"0","summary":"药械审批国家医保局发布2026年国家医保目录调整工作方案5月31日,国家医保局发布《2026年国家基本医疗保险、生育保险和工伤保险药品目录及商业健康保险创新药品目录调整工作方案》《2026年国家基本医疗保险、生育保险和工伤保险药品目录及商业健康保险创新药品目录调整申报指南》《谈判药品续约规则》以及《非独家药品竞价规则》。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606013755285483.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606013755285483.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0175","BK0188","600513","BK0183","300562","BK0216","600521","BK0196","BK0070","BK0109","BK0201","BK0096","BK0251","IPOS","BK0250","BK0187","BK0012","301263","BK0239","301096","BK0114","BK0028","BK0185","600196","BK0060"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1783976560127,"stockEarnings":[{"period":"1week","weight":-0.0773},{"period":"1month","weight":0.0578},{"period":"3month","weight":-0.1416},{"period":"6month","weight":-0.2152},{"period":"1year","weight":-0.3793},{"period":"ytd","weight":-0.173}],"compareEarnings":[{"period":"1week","weight":-0.0315},{"period":"1month","weight":-0.0292},{"period":"3month","weight":-0.028},{"period":"6month","weight":-0.0515},{"period":"1year","weight":0.115},{"period":"ytd","weight":-0.0139}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"广东泰恩康医药股份有限公司","boardCode":"AI0051","boardName":"批发业","stockholders":"12996人(较上一季度减少0.84%)","perCapita":"28031股","listingDate":"2022-03-29","address":"广东省汕头市龙湖区泰山北路万吉南二街8号A幢","registeredCapital":"51059万元","survey":" 广东泰恩康医药股份有限公司的主营业务是代理运营及研发、生产、销售医药产品、医疗器械、卫生材料并提供医药技术服务与技术转让等。公司的主要产品是盐酸达泊西汀片、他达拉非片、枸橼酸西地那非口崩片、和胃整肠丸、沃丽汀、风油精、六味地黄丸、藿香正气丸、奥硝唑注射液。公司自主研发的“爱廷玖”盐酸达泊西汀片为首个国产PE用药,2020年8月正式投放市场,目前在达泊西汀院外渠道市场稳居头部地位,尤其在线下零售市场形成显著品牌优势。","listedPrice":19.93},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"泰恩康(301263)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供泰恩康(301263)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"泰恩康,301263,泰恩康股票,泰恩康股票老虎,泰恩康股票老虎国际,泰恩康行情,泰恩康股票行情,泰恩康股价,泰恩康股市,泰恩康股票价格,泰恩康股票交易,泰恩康股票购买,泰恩康股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"泰恩康(301263)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供泰恩康(301263)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}